Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 1333341)

Published in Brain Res on October 02, 1992

Authors

J P Herman1, W E Cullinan, E A Young, H Akil, S J Watson

Author Affiliations

1: Department of Anatomy and Neurobiology, University of Kentucky Medical Center, Lexington 40536-0084.

Articles citing this

The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci (2006) 1.96

The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology (2008) 1.45

Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes. Mol Psychiatry (2008) 1.18

A detailed characterization of loud noise stress: Intensity analysis of hypothalamo-pituitary-adrenocortical axis and brain activation. Brain Res (2005) 1.16

Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors. Neuropsychopharmacology (2015) 1.04

Chronic stress-induced alterations of dendritic spine subtypes predict functional decrements in an hypothalamo-pituitary-adrenal-inhibitory prefrontal circuit. J Neurosci (2013) 0.95

Developmental pathology, dopamine, stress and schizophrenia. Int J Dev Neurosci (2010) 0.93

Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders. Neurosci Biobehav Rev (2015) 0.86

Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J Psychiatr Res (2012) 0.85

Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice. Neurotoxicology (2012) 0.85

Prenatal alcohol exposure is associated with altered subcellular distribution of glucocorticoid and mineralocorticoid receptors in the adolescent mouse hippocampal formation. Alcohol Clin Exp Res (2013) 0.83

Successful use of inhaled nitric oxide to decrease intracranial pressure in a patient with severe traumatic brain injury complicated by acute respiratory distress syndrome: a role for an anti-inflammatory mechanism? Scand J Trauma Resusc Emerg Med (2009) 0.81

Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice. Front Neuroendocrinol (2014) 0.79

Stress-induced decreases in local cerebral glucose utilization in specific regions of the mouse brain. BMC Res Notes (2011) 0.77

Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications. J Clin Invest (1994) 0.76

Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy. Physiol Behav (2016) 0.75

The impact of hippocampal lesions on trace-eyeblink conditioning and forebrain-cerebellar interactions. Behav Neurosci (2015) 0.75

Articles by these authors

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci (1997) 5.41

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci (1995) 3.00

Anatomy of CNS opioid receptors. Trends Neurosci (1988) 2.82

Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem (1993) 2.81

Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience (1995) 2.69

Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (1991) 2.63

Endogenous opioids: biology and function. Annu Rev Neurosci (1984) 2.54

Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci (1987) 2.53

Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci (2000) 2.42

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38

Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science (1976) 2.35

Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol (1994) 2.33

Controlling signaling with a specifically designed Gi-coupled receptor. Proc Natl Acad Sci U S A (1998) 2.22

Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19

Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci U S A (1990) 2.07

Molecular cloning of a novel melanocortin receptor. J Biol Chem (1993) 1.89

Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol (1993) 1.83

Analgesia from electrical stimulation in the brainstem of the rat. Science (1971) 1.81

Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci (1999) 1.80

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry (1998) 1.80

Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol (1999) 1.77

Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J Comp Neurol (1999) 1.76

Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry (1991) 1.75

Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron (1993) 1.68

Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol (1996) 1.61

Social stress in hamsters: defeat activates specific neurocircuits within the brain. J Neurosci (1997) 1.60

Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat (1995) 1.56

Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci (1990) 1.56

Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology (1997) 1.55

Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol (1999) 1.52

Stress-restress: effects on ACTH and fast feedback. Psychoneuroendocrinology (1997) 1.51

Differential expression of protein phosphatase 1 isoforms in mammalian brain. J Neurosci (1995) 1.50

Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci (1989) 1.50

A biochemical function for attractin in agouti-induced pigmentation and obesity. Nat Genet (2001) 1.49

Neuroendocrine and behavioral responses and brain pattern of c-fos induction associated with audiogenic stress. J Neuroendocrinol (1997) 1.48

Differential binding properties of oripavines at cloned mu- and delta-opioid receptors. Eur J Pharmacol (1999) 1.48

Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry (1998) 1.48

Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A (1993) 1.47

Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42

A food predictive cue must be attributed with incentive salience for it to induce c-fos mRNA expression in cortico-striatal-thalamic brain regions. Neuroscience (2011) 1.41

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther (1996) 1.39

Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38

Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol (1989) 1.38

Common peroneal nerve injury during varicose vein operation. Eur J Vasc Endovasc Surg (2005) 1.38

Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat (1997) 1.37

Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav (2000) 1.34

Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol (1992) 1.34

mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res (1994) 1.34

Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop. Eur J Pharmacol (2000) 1.32

Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior. Psychopharmacology (Berl) (2001) 1.32

Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci (1998) 1.31

Differential expression of c-fos mRNA within neurocircuits of male hamsters exposed to acute or chronic defeat. J Neuroendocrinol (1999) 1.31

Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res (1999) 1.31

Pain reduction by electrical brain stimulation in man. Part 2: Chronic self-administration in the periventricular gray matter. J Neurosurg (1977) 1.30

Nonopiate effects of dynorphin and des-Tyr-dynorphin. Science (1982) 1.29

Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res (1995) 1.29

Immunocytochemical localization of methionine enkephalin: preliminary observations. Life Sci (1977) 1.28

Evidence for two separate opiate peptide neuronal systems. Nature (1978) 1.28

Fire mosaics and reptile conservation in a fire-prone region. Conserv Biol (2012) 1.28

Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J Neurosci (1993) 1.28

Workshop on schizophrenia. Proc Natl Acad Sci U S A (1997) 1.28

Review of the radiation exposure of the UK population. J Radiol Prot (2005) 1.27

Direct evidence that the glucocorticoid receptor binds to hsp90 at or near the termination of receptor translation in vitro. J Biol Chem (1989) 1.25

Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. J Neurosci (1998) 1.25

The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res (1995) 1.24